- Azathioprine in the therapy of paediatric inflammatory bowel disease - part I: treatment indications, dosing and thiopurine-related adverse events2021 | Second Faculty of Medicine
- Azathioprine in the therapy of paediatric inflammatory bowel disease - part II: pharmacodynamics, pharmacokinetics, and the possibilities of measuring its metabolites in clinical practice2021 | Second Faculty of Medicine
- Complication of immunosupresive therapy thiopurine in patients with inflammatory bowel diseasePublication without faculty affiliation
- Identification of predictive factors of AZA/6-MP treatment outcome in peadiatric Crohn's disease2017 | Second Faculty of Medicine
- Augmenting Clinical Interpretability of Thiopurine Methyltransferase Laboratory Evaluation2014 | Second Faculty of Medicine
- Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn's Disease on Combination Therapy? A Multicenter Prospective Observational Study2021 | First Faculty of Medicine, Second Faculty of Medicine
- Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II)2018 | First Faculty of Medicine
- Thiopurine intolerance-causing mutations in NUDT15 induce temperature-dependent destabilization of the catalytic site2019 | Faculty of Science
- Prediction of thiopurine failure in pediatric Crohn's disease: pediatric IBD Porto group of ESPGHAN2023 | Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Mathematics and Physics, Faculty of Medicine in Hradec Králové
- Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms2006 | First Faculty of Medicine
- Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms2006 | Faculty of Physical Education and Sport
- Azathioprine myelosupression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms2006 | First Faculty of Medicine
- Azathioprine myelosupression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms2006 | Faculty of Physical Education and Sport
- Effects of the activity of thiopurin metyltransferase on the results of long-term immunosupressive therapy with azathioprin (6-mercaptopurine) in patients with inflammatory bowel diseases2002 | Faculty of Physical Education and Sport
- Long-term therapy of idiopathic inflammatory bowel disease2012 | First Faculty of Medicine
- Thiopurine methyltransferase (TPMT) activity in patients with IBD: the influence on the results of the long term azathioprine (AZA) therapyPublication without faculty affiliation
- Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine2007 | First Faculty of Medicine
- Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine2007 | Faculty of Physical Education and Sport
- Prediction of Thiopurine Metabolite Levels Based on Haematological and Biochemical Parameters2019 | Second Faculty of Medicine
- Polymorphisms of the TPMT gene in the Czech healthy population and patients with inflammatory bowel disease2008 | First Faculty of Medicine
- Thiopurine methyltransferase activity, 6-methylmercaptopurin and 6-thioguanin levels in patients with IBD: the influence on adverse events of azathioprine therapyPublication without faculty affiliation
- Thiopurine methyltransferase activity, 6methylmercaptopurine and 6-thioguanine levels in patients with IBD: the influence on adverse events of azathioprine therapyPublication without faculty affiliation
- Effects of the activity of thiopurin metyltransferase on the results of long-term immunosupressive therapy with azathioprin (6-mercaptopurine) in patients with inflammatory bowel diseases2002 | First Faculty of Medicine
- Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis2011 | First Faculty of Medicine
- Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN2018 | Second Faculty of Medicine
- When and how to proceed with postoperative recurrence of Crohn's disease2016 | First Faculty of Medicine
- Editorial: Idiopathic intestinal inflammation in childhood2017 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition2018 | Second Faculty of Medicine
- COST action B25 - Physiologically based pharmaco-toxico-kinetics and dynamics: expert meeting on "From models to individual patients" (from in silico to bedside)Publication without faculty affiliation
- Sclerosing cholangitis in children with inflammatory bowel disease2023 | Second Faculty of Medicine
